Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Lepromatous leprosy with laryngeal involvement.

de Guia C, Venida-Tablizo A. Indian journal of dermatology, venereology and leprology. 2021;
Download PDF
Publication

Lucio's phenomenon: A systematic literature review of definition, clinical features, histopathogenesis and management.

Cipriani Frade M, Coltro P, Filho FB, et al. Indian journal of dermatology, venereology and leprology. 2021;
Download PDF
Publication

BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.

van Hooij A, van den Eeden S, Khatun M, et al. Vaccine. 2021;
Download PDF
Publication

Mycobacterium leprae Induces Neutrophilic Degranulation and Low-Density Neutrophil Generation During Erythema Nodosum Leprosum.

Tavares I, Dos Santos JB, Pacheco FDS, et al. Frontiers in medicine. 2021;
Download PDF
Publication

A new paradigm for leprosy diagnosis based on host gene expression.

Leal-Calvo T, Avanzi C, Mendes M, et al. PLoS pathogens. 2021; 17 (10) : e1009972.
Download PDF
Publication

Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.

Chew R, Woods M. The American journal of tropical medicine and hygiene. 2021;
Download PDF
Publication

Autochthonous North American Leprosy: A Second Case in Canada.

Naidu P, Sharma R, Kanji J, et al. Infectious disease reports. 2021; 13 (4) : 917-923.
Download PDF
Publication

Epidemiological review of leprosy in WHO's Western Pacific Region: 1991-2019.

Rahevar K, Morishita F, Oh K, et al. Western Pacific surveillance and response journal : WPSAR. 2021; 12 (3) : 34-46.
Download PDF
Publication

Leprosy in children in Cuba: Epidemiological and clinical description of 50 cases from 2012-2019.

Rumbaut Castillo R, Gascón LCH, Ruiz-Fuentes JL, et al. PLoS neglected tropical diseases. 2021; 15 (10) : e0009910.
Download PDF
Publication

Reductive Power Generated by Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis.

Rosa T, Marques M, DeBoard Z, et al. Frontiers in cellular and infection microbiology. 2021;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 239
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD